| Michael Riveccio, PHARMD | |
|
17 Docker Dr, Wallingford, CT 06492-5200 | |
| (203) 530-1246 | |
| Not Available |
| Full Name | Michael Riveccio |
|---|---|
| Gender | Male |
| Speciality | Pharmacist |
| Location | 17 Docker Dr, Wallingford, Connecticut |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1356880645 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | PCT.0010625 (Connecticut) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Michael Riveccio, PHARMD 17 Docker Dr, Wallingford, CT 06492-5200 Ph: (203) 530-1246 | Michael Riveccio, PHARMD 17 Docker Dr, Wallingford, CT 06492-5200 Ph: (203) 530-1246 |
News Archive
The Multiple Myeloma Research Consortium (MMRC) announced today that data from 13 of its clinical trials and three from the Multiple Myeloma Research Foundation (MMRF) Genomics Initiative, which analyzes tissue samples from the MMRC tissue bank, have been selected for oral or poster presentations at the upcoming 51st Annual Meeting of the American Society of Hematology (ASH) to be held in New Orleans from December 5-8, 2009.
Throughout her distinguished career, cancer researcher Dafna Bar-Sagi, PhD, has made fundamental contributions to the understanding of the mechanisms that drive the disease.
Workplaces that reduce job strain could prevent up to 14 percent of new cases of common mental illness from occurring, according to new research led by the Black Dog Institute.
Many of the approximately 1,500 deaths in the U.S. each year due to anaphylaxis, a sudden serious allergic reaction, could be prevented if more people knew the symptoms and the immediate treatment needed to survive.
Oncolytics Biotech Inc. announced today that the Cancer Therapy Research Center at the University of Texas Health Science Center (CTRC) has started patient enrolment in a U.S. Phase 2 clinical trial using intravenous administration of REOLYSIN(R) in combination with paclitaxel and carboplatin in patients with metastatic melanoma.
› Verified 7 days ago
Naima Fazel, PHARMD, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 141 Deepwood Ln, Wallingford, CT 06492 Phone: 203-376-5499 | |
Deedee Ibeku, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 605 N Colony Rd, Wallingford, CT 06492 Phone: 203-265-3600 | |
Jerry Edouard, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 930 N Colony Rd, Wallingford, CT 06492 Phone: 203-265-6972 | |
Pasquale Nastri Iii, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3 Crystal Ln, Wallingford, CT 06492 Phone: 203-269-4943 | |
Louis Houle, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 509 North Colony Road, Wallingford, CT 06492 Phone: 203-265-3600 | |
Dr. Entela E Curri, PHARMACIST Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 605 N Colony Rd, Wallingford, CT 06492 Phone: 203-265-3600 | |
Doreen Gail Barile, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 846 North Colony Road, Wallingford, CT 06492 Phone: 203-626-7765 Fax: 203-626-7767 |